BACKGROUND Squamous cell carcinoma (SCC), which has one of the highest incidences of all cancers in the United States, is an age-dependent disease, with the majority of these cancers diagnosed in people age 70 and older. Recent findings have led to a new hypothesis on the pathogenesis of SCC.
T he translation of basic research findings into clinically useful therapies can be long and sometimes arduous. This review article highlights an example of an ongoing "bench to bedside" approach by linking the basic science of senescence and aging with a potential prophylactic treatment for squamous cell carcinoma (SCC). For decades, we have understood that the exposure of epidermal keratinocytes to ultraviolet light B (UVB) irradiation leads to a dose-dependent accumulation of DNA damage. [1] [2] [3] [4] [5] [6] Emerging in vitro basic research has uncovered the paramount importance of the insulin-like growth factor 1/insulin-like growth factor-1 receptor (IGF-1/IGF-1R) pathway in the response of skin keratinocytes to the UVB wavelengths found in sunlight. [7] [8] [9] We have demonstrated that the severity of DNA damage, whether the IGF-1/IGF-1R pathway is active or inactive during exposure to sunlight, and the cellular senescence profile of fibroblasts seen in aged skin determine keratinocyte response to UVB exposure. [7] [8] [9] In particular, the abundant expression of IGF-1 in young adult skin is greatly lower in geriatric skin. This loss of IGF-1 expression renders geriatric epidermis deficient in IGF-1R activation, which leads to an inappropriate UVB response. Keratinocytes with IGF-1 in their environment respond to moderate UVB doses, which induce DNA damage by becoming senescent, [9] [10] [11] but without IGF-1, these keratinocytes can continue to proliferate, with DNA mutations, which can result in premalignant cells. These critical observations have been made in vitro and in vivo, leading to the development of new potential therapeutic targets. 12, 13 These new targets aim to treat the rising incidence of SCC in the geriatric population through wounding modalities designed to restore IGF1/IGF-1R pathways by reversing the fibroblast senescence phenotype. In this review, we examine translational therapies being used in vivo based on in vitro basic science research.
Involvement of Age and UVB Exposure in Pathogenesis of SCC
The primary environmental factor influencing the development of skin cancer is exposure to the spectrum of UV wavelengths found in sunlight. [1] [2] [3] [4] [5] Furthermore, there is a strong correlation between the development of skin cancer and increasing age 14, 15 ; 80% of nonmelanoma skin cancers (NMSCs) are diagnosed after the age of 60, indicating that age is a second major risk factor for the development of these skin cancers, 21-23 but the mechanism responsible for aging-associated NMSC has not been adequately defined. Epidemiologic studies have reported that excessive sun exposure occurring in the first two decades of life can lead to UVB-induced mutations in clones of initiated keratinocytes. [17] [18] [19] [20] These clonal populations of altered keratinocytes persist in the epidermis and eventually obtain growth advantages through the accumulation of additional mutations in essential regulatory genes. The long incubation period between the original UVB-induced mutation and the development of a phenotypic NMSC is attributed to the time required to acquire the minimal number of chromosomal mutations that results in the appearance of a discernible tumor. [17] [18] [19] [20] This hypothesis relies on two assumptions-that the amount of sun exposure before age 20 is excessive and that the response of the skin to sun exposure remains constant throughout the lifespan-but recent studies have shown that these assumptions may not be entirely correct. These published reports suggest that nearly 80% of lifetime exposure to sunlight occurs after the age of 18. 21 These data indicate that exposure to sunlight is relatively constant over our lifetime and not excessive in our toddler and adolescent years. 21 In addition to this recent documentation of lifetime sun exposure, it has been well-accepted that the use of sunscreen can protect against actinic keratoses and NMSC in susceptible geriatric populations. [22] [23] [24] These findings may suggest that the acquisition of actinic neoplasia is an ongoing process, a critical concept for future protective therapeutic strategies. Second, the ability to repair DNA damage diminishes as we age, in general 25, 26 and specifically in skin. 27, 28 Therefore, a UVB injury to keratinocytes obtained later in life may have different consequences and outcomes than UVB damage occurring earlier in life. Basic science bench research has shown that one of the factors that accounts for differences in the UVB response in older populations is the IGF-1/IGF-1R signal transduction pathway. [7] [8] [9] [10] [11] [12] [13] These recent findings have identified new concepts to treat precancerous actinic damage by preventing the development of skin cancer in susceptible older adults. These new concepts were based on a correlation between the basic science findings and clinical observations and that greater cellular senescence along with inactivation of the IGF1/IGF-1R pathway occurs in aged skin. These two observations are also critical in the response (appropriate vs inappropriate) of keratinocytes to UVB exposure and propagation of DNA damage into procarcinogenic changes.
Involvement of Aging Dermal Fibroblasts and Reduced IGF-1 in NMSC Pathogenesis
Our basic research findings are based on the stromal changes in aging skin, which affect how keratinocytes respond to UVB irradiation. When the epidermis is exposed to UVB, the genomes of the epidermal keratinocytes become damaged. 4 If this DNA damage is allowed to persist, alterations (or mutations) in keratinocyte genes will accumulate, leading to actinic neoplasia. Keratinocytes have innately developed extensive protective measures to handle UVB-induced DNA damage. The IGF-1/IGF-1R signal transduction pathway in human skin is an excellent example of the interdependent relationship between the fibroblasts in the dermis and the keratinocytes in the epidermis. Human epidermal keratinocytes express the heterodimeric IGF-1R on their cell surface, but they do not synthesize the corresponding ligand: IGF-1. Activation of the keratinocyte IGF-1R occurs primarily through the production and secretion of IGF-1 by papillary dermal fibroblasts. As dermal fibroblasts age and become senescent in vivo, their expression of IGF-1 falls significantly, resulting in inactive IGF-1R in geriatric epidermal keratinocytes. This reduction in the activity of IGF-1R directly influences how geriatric keratinocytes respond to UVB irradiation. In young adult skin, where IGF-1 expression sufficiently activates the keratinocyte IGF-1R, moderate levels of UVB irradiation lead to UVB-induced DNA damage that cannot be fully repaired, which results in the keratinocyte becoming senescent. In this manner, the IGF-1R-dependent induction of UVBinduced senescence is a tumor evasion response, which prevents keratinocytes from establishing UVBinduced mutations in proliferative cells without compromising the barrier function of the epidermis, but in geriatric skin containing a significant proportion of inactive IGF-1R, the same dose of UVB irradiation does not elicit the senescent response in keratinocytes and allows geriatric keratinocytes to replicate UVB-damaged DNA. Therefore, the senescence-associated tumor evasion response does not protect geriatric keratinocytes, which have greater potential for the formation of mutated, replicating keratinocytes. Consequently, if the IGF-1/ IGF-1R pathway is active during UVB exposure (with keratinocytes being exposed to adequate levels of IGF-1 from fibroblasts), three appropriate responses occur to prevent propagation of mutations and initiation of carcinogenic processes; mildly damaged DNA is completely repaired and the keratinocytes survive, keratinocytes with extensively-damaged DNA that cannot be completely repaired are removed by apoptosis, or keratinocytes with intermediate levels of DNA damage that cannot completely repair the genome undergo stress-induced senescence that removes the cells from the cell cycle while maintaining the integrity of the tissue. [7] [8] [9] [10] [11] [12] [13] If the IGF-1/IGF-1R pathway is inactive during physiologically relevant sunlight exposure, an inappropriate response occurs in which keratinocytes with unrepaired DNA damage are able to continue proliferating with potentially mutated genes.
This in vitro bench discovery that the IGF-1R activation status of epidermal keratinocytes is crucial in response to UVB led us to postulate the clinical relevance of low IGF-1 expression and IGF-1R activation and more importantly whether this may be correlated to susceptibility of aging individuals to skin cancer in vivo. When comparing skin samples of young (<25) and older ( 65) volunteers, it was determined that geriatric skin accumulates increasing proportions of senescent fibroblasts. [7] [8] [9] [10] [11] [12] [13] This high proportion of senescent fibroblasts in geriatric skin leads to a decrease in dermal IGF-1 production and a corresponding deficiency in epidermal IGF-1R activation. 3 The lack of IGF-1R activation during UVB exposure results in an inappropriate UVB response, resulting in the occurrence of basal keratinocytes proliferating, with DNA damage in geriatric skin. 7 Most importantly, the injection of IGF-1 into the dermis of geriatric subjects before UVB irradiation restores the appropriate UVB response, 7 indicating that increased activity of the epidermal keratinocytes IGF-1R could overcome the inappropriate UVB response.
These published data shed new light on the explanation for the greater incidence of SCC with age. [14] [15] [16] This new hypothesis states that the selection of initiated epithelial cells is accelerated in aged tissue because alterations in gene expression by senescent fibroblasts support epithelial cell growth. 7, 8 Specifically, this new paradigm indicates that the accumulation of senescent fibroblasts in geriatric dermis leads to a silencing of IGF-1 expression in the skin, resulting in deficient activation of IGF-1R in epidermal keratinocytes, causing an inappropriate UVB-response in keratinocytes. This IGF-1-deficient state results in the formation of proliferating keratinocytes containing DNA mutations in response to relatively low levels of UVB exposure (~1 minimal erythema dose (MED)) and subsequently photocarcinogenesis. 7, 8 This new paradigm explains previous observations, such as the ability of sunscreen use to decrease actinic neoplasia in susceptible populations. [22] [23] [24] Because UV light can also result in photoaging, with greater fibroblast senescence (and less production of IGF-1), this paradigm also explains how cumulative exposure of sunlight leads to actinic neoplasia. Given the findings that the lack of endogenous IGF-1 in geriatric skin results in an inappropriate procarcinogenic response to low UVB exposure, which local injection of exogenous IGF1 reversed, alternative prophylactic therapies to restore IGF-1 levels in geriatric skin were tested.
Theoretical Basis for Prophylactic Wounding Therapies to Prevent SCC
Inasmuch as the increase in SCC incidence and its associated morbidity and cost make actinic neoplasia a significant disease process, the prevention of these tumors has clinical importance. Preventing cancers before they develop by targeting precancerous changes is an attractive and sometimes elusive goal. For patients with established actinic keratosis precursor lesions, strategies include destruction using physical modalities such as cryotherapy (freezing), electrosurgery (burning), curettage (scraping), photodynamic therapy (PDT) with an adjuvant, or topical medicines such as 5-fluorouracil or immune-mediated destruction with topical imiquimod. [30] [31] [32] [33] [34] [35] Moreover, treatment of these early lesions is essential to prevent progression to SCC. Treatment of recurrent skin cancer is usually less successful than treatment of primary skin cancer. Most recurrences occur in the first 2-5 years, so patients with SCC need close monitoring, which results in higher costs to the healthcare system.
Although somewhat effective in treating established precancerous or low-grade lesions, some of these treatment strategies are extremely disfiguring and place an enormous financial burden on the healthcare system. In addition, these treatments target only the precancerous or tumor cells, which may not treat the underlying process by which aged skin is more susceptible to neoplasia. If, as our research indicates, a major deciding feature of aging-associated SCC initiation is an inappropriate UVB response by geriatric keratinocytes due to the lack of IGF-1 and senescence of geriatric dermal fibroblasts, this provides the impetus for novel treatment strategies targeting senescent dermal fibroblasts. [7] [8] [9] [10] [11] [12] [13] Therefore, treatment modalities that restore collagen expression, remove senescent fibroblasts, and recruit new fibroblasts, thereby normalizing the secretion of IGF-1, could potentially prevent the initiation of UVB-induced carcinogenesis caused by ongoing sun exposure. As a result, studies using dermabrasion 12 and fractionated laser resurfacing (FLR) 13 have been pursued to determine whether the dermal wounding response resulting from these dermal rejuvenation therapies can restore the appropriate UVB response in geriatric skin.
Use of Dermabrasion and FLR to Reverse Senescent Pathology
Dermabrasion, using number 60 grain sandpaper to create a wound extending into the papillary dermis, was the first wounding modality tested. Older (age 65) volunteers without diabetes mellitus underwent dermabrasion to a 5-by 5-cm area of sun-protected buttocks skin. After 3 months, the subjects were treated with 1 MED (approximately 350 J/m 2 ) of UVB to a 5-by 5-mm area of previously wounded skin or nonwounded skin on contralateral buttocks skin. Twenty-four hours after localized UVB irradiation, subjects underwent punch biopsies of wounded unirradiated, wounded radiated, unwounded unirradiated, and wounded irradiated skin. Wounding using dermabrasion resulted in less-senescent fibroblasts and higher levels of IGF-1 messenger RNA levels. 12 These values in wounded geriatric skin were similar to those found in skin from younger (age <30) subjects. Ultraviolet light B irradiation of unwounded geriatric skin resulted in the formation of initiated (UVB damage in proliferating cells) basal keratinocytes, although consistent with the normalization of numbers of senescent fibroblasts and IGF-1 levels, UVB treatment of previously dermabraded skin did not result in the formation of initiated keratinocytes. These studies provided the first evidence that wounding of geriatric skin could reverse this inappropriate procarcinogenic UVB response.
Although the results of these studies were exciting, the use of dermabrasion for wide-spread areas of skin as a prophylactic agent would not be practical because of the significant morbidity of this treatment modality. To that end, the ability to wound using FLR to correct the inappropriate UVB response in geriatric volunteers was tested. Recently published studies 13 found that FLR treatment to sun-protected buttocks and sun-exposed forearm skin in geriatric volunteers resulted in similar decreases in numbers of senescent fibroblasts, upregulation of dermal IGF-1 levels, and normalization of the acute UVB response. The effects of FLR were similar to that of the moreinvasive dermabrasion. That the relatively benign FLR procedure, increasingly used for its "cosmetic" effects, could also "normalize" geriatric UVB protection suggests that this modality can also protect against future actinic neoplasia. (See Figure 1 for a description of the hypothesized protective effect of FLR on photocarcinogenesis.) Ongoing studies examining the long-term effectiveness of these wounding modalities on dermal IGF-1 production and numbers of senescent fibroblasts are in progress, and preliminary studies suggest that these effects are seen for at least 2 years after FLR (unpublished data).
Conclusions and Future Directions
Preclinical in vitro data leading to the ongoing in vivo clinical studies described in this review represent a new paradigm. These studies are exciting not only because they provide an explanation for SCC, but also because they provide the impetus for novel interventions that could be used to prevent actinic neoplasia. Photorejuvenation therapies are gaining widespread acceptance to allow patients to appear younger. That these therapies may potentially protect against future skin precancers and cancers is a "nice bonus." Future avenues of investigation, including following our cohort of laser-treated subjects longer, as well as examination of wounding effects in immunosuppressed populations who are at high-risk for developing SCCs. The combination of chemopreventative 36, 37 and prophylactic wounding therapies [38] [39] [40] [41] [42] could prove to be effective at controlling the incidence of SCC in high-risk older adults. These studies will provide well-characterized patient samples that will be useful for further indepth studies evaluating the effects of dermal wounding in this population. The successful development of the prophylactic therapies described in this review may have a major effect on how SCCs are prevented in susceptible individuals.
